CURE: One app, all things health
CURE Group GmbH is a Berlin-based pharmacy delivery platform that connects independent German and French pharmacies with consumers via its GetCure mobile app and B2B2C integrations with Lieferando and Wolt, enabling sub-45-minute OTC and e-prescription medication delivery through an asset-light, POS-integrated pharmacy network.
- Company typePrivate
- Founded2021
- HeadquartersBerlin, Germany
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What CURE: One app, all things health does
CURE Group GmbH is a Berlin-based healthcare delivery platform founded in December 2021 by Ali El-Ali (CEO) and Manuel Aberle (COO). The company operates a two-sided digital infrastructure connecting independent pharmacies in Germany and France with end consumers via its own consumer mobile app (GetCure, iOS/Android) and B2B2C integrations with major delivery aggregators Lieferando and Wolt. Orders are routed to the nearest partner pharmacy, which fulfills and dispatches delivery via CURE's rider fleet or the pharmacy's own delivery service, with target fulfillment windows of 30–45 minutes.
The core technology stack centers on real-time POS integration with all major German pharmacy management systems (ADG, Awinta, Lauer-Fischer/CGM, Pharmatechnik, ApoSoft, Apotechnik) and French POS Offisanté, enabling automated inventory checks that prevent orders for out-of-stock products. The platform is marketed as an "AI-driven" copilot that automates order routing, availability verification, and rider dispatch, with a "hubless" asset-light architecture that avoids company-owned micro-fulfillment centers. The product catalog covers 3,000+ OTC SKUs (expanded by 500+ in June 2023 to include beauty, supplements, vitamins, sleep aids), and an E-Rezept module launched in August 2023 supports paper and electronic prescription upload and delivery across six German cities.
CURE generates revenue primarily through per-order transaction fees charged to partner pharmacies, with no fixed subscription costs and no minimum contract terms, plus commercial commission arrangements with delivery aggregators that surface CURE's pharmacy network within their apps. Pharmacies are promised up to 1,200 additional monthly orders, with reported outcomes of +20% orders and +30% revenue per partner. Consumers receive free delivery on both OTC and prescription medications. Total disclosed funding stands at approximately €19.7 million across a €4.7M seed (January 2022) and a €15M Series A led by Breega (September 2022). The company operates as CURE Group GmbH in Germany (Berlin HQ, active in 7+ cities) and CURE Group France SAS in Paris.
CURE: One app, all things health firmographics
Firmographics- Name
- CURE: One app, all things health
- Legal name
- CURE Group GmbH
- Website
- https://getcure.app
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CURE Group GmbH is a Berlin-based pharmacy delivery platform that connects independent German and French pharmacies with consumers via its GetCure mobile app and B2B2C integrations with Lieferando and Wolt, enabling sub-45-minute OTC and e-prescription medication delivery through an asset-light, POS-integrated pharmacy network.
- Ownership category
- akta.pro rank
CURE: One app, all things health industry classification
Industry- Product category
- Pharmacy Delivery Platform
- NAICS
- Pharmacies and Drug Retailers (456110)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Telepharmacy & Prescription Fulfillment Marketplaces (HLALALAF)
- akta.pro secondary industry
- Mail-Order & Home Delivery Pharmacies (HLAFALAD)
Keywords
Where CURE: One app, all things health is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
CURE: One app, all things health business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Commission per Order (Pharmacy-side): CURE charges partner pharmacies a small transaction fee per order fulfilled through the platform. There are no fixed subscription costs for the pharmacy. This is the primary revenue stream, generated when customers order via Lieferando, Wolt, or the CURE app and the pharmacy receives and fulfills the order.
- B2B Platform Licensing / Commission from Delivery Aggregators: Revenue is also generated from commercial arrangements with delivery platforms (Lieferando, Wolt) that integrate CURE's pharmacy network into their apps. CURE acts as the pharmacy-fulfillment layer, earning a share of the transaction value when consumers order pharmacy products through the aggregator's interface.
- Prescription Delivery (E-Rezept): E-prescription orders are delivered by partner pharmacies. CURE facilitates the prescription upload, validation, and delivery coordination. Delivery for prescription medications is offered free of charge to consumers; the pharmacy monetizes the prescription fill through statutory or private insurance reimbursement.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Partner Pharmacy — No fixed cost, per-order fee only |
| Freemium | Pay-as-you-go | Consumer — Free delivery (OTC and prescription) |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
CURE: One app, all things health product offering
Product offeringCore offering
CURE operates an AI-driven pharmacy platform that connects local pharmacies with end consumers through a unified order management dashboard integrated with delivery aggregators (Lieferando, Wolt) and its own consumer mobile app. Pharmacies receive orders across multiple channels in a single dashboard with automatic POS-based availability checks, while consumers can order over-the-counter and prescription medications (via e-prescription upload) for home delivery within approximately 30 minutes.
Product overview
CURE operates as a unified health platform combining a consumer mobile app (GetCure App) for ordering medications with a B2B platform (CURE Order Platform) for pharmacies. The ecosystem includes: (1) GetCure App - consumer-facing iOS/Android app for ordering OTC medications and pharmacy products for home delivery; (2) CURE Order Platform - B2B solution connecting pharmacies with delivery platforms like Lieferando and Wolt, generating up to 1,200 additional monthly orders per pharmacy; (3) CURE E-Rezept Service - electronic prescription handling module enabling prescription medication delivery; (4) CURE Rider Delivery - proprietary last-mile delivery service; and (5) CURE Product Catalog - expanded assortment including health, beauty, and wellness products. The platform acts as an AI-powered copilot digitizing local pharmacies while maintaining their customer relationships.
Differentiator
Problem solved
Functional benefit
Products and services
- CURE Order Platform B2B platform for pharmacies that enables them to receive and manage online orders through integration with delivery services like Lieferando and Wolt. Connects local pharmacies with digital business models, providing up to 1,200 additional orders per month per pharmacy, with POS-based automatic inventory checking and a unified dashboard.
- GetCure App Consumer-facing mobile application (iOS and Android) enabling users to order over-the-counter medications and pharmacy products for home delivery. Users can select from thousands of products, place orders at the nearest partner pharmacy, and track deliveries in real time.
- CURE E-Rezept Service Electronic prescription delivery service allowing users to scan or upload paper or digital prescriptions via the CURE app and have prescribed medications delivered to their home. Includes pharmacist consultation and same-day or next-day delivery.
- CURE Rider Delivery Last-mile delivery service using CURE Riders to pick up orders from partner pharmacies and deliver to consumers. Provides real-time tracking and approximately 30-45 minute delivery timeframes.
Quantifiable outcome
- Up to 1,200 additional orders per month per partner pharmacy
- +4 more outcomes
Companies that use CURE: One app, all things health
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
CURE: One app, all things health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration10 records
AI capability2 records
Feature6 records
CURE: One app, all things health partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core.
- WoltcoreWolt (a Finnish delivery platform operating in 25+ countries and 500+ cities) integrated CURE's pharmacy network into its consumer app, enabling Wolt users to order OTC medications from local German pharmacies for home delivery (~35 minutes). Launched initially in Berlin, Hamburg, Frankfurt, Stuttgart, and Hannover with 9 pharmacies, with planned expansion to ~70 pharmacies across all Wolt cities in Germany. This is a core B2B2C distribution partnership.
- Lieferando (Just Eat Takeaway Germany)coreLieferando integrated CURE's pharmacy platform, allowing its German users to order non-prescription medications via the Lieferando app with delivery by CURE's rider fleet from partner pharmacies. This nationwide cooperation positions CURE as the pharmacy-fulfillment layer for Just Eat Takeaway's German grocery and delivery operations.
- ADG (Apotheken-Daten-Gesellschaft)coreCURE's platform is fully compatible with ADG pharmacy POS/cash register systems, enabling automated inventory checks and order processing for partner pharmacies using ADG. This integration is a prerequisite for pharmacy onboarding and ensures only in-stock products can be ordered.
- Awinta (Noventi)coreCURE integrates with Awinta pharmacy management systems, allowing partner pharmacies running Awinta software to automatically sync inventory and receive CURE orders within their existing workflow.
- Lauer-Fischer (CGM)coreCURE is compatible with Lauer-Fischer pharmacy POS systems (part of CGM / CompuGroup Medical), enabling partner pharmacies to process CURE orders without additional hardware or manual data entry.
- PharmatechnikcoreCURE integrates with Pharmatechnik pharmacy management software, one of Germany's widely deployed pharmacy IT systems, to enable seamless order routing and inventory synchronization.
- ApoSoftcoreCURE is compatible with ApoSoft pharmacy software, allowing partner pharmacies running ApoSoft to automatically sync product availability and receive CURE orders within their existing systems.
- ApotechnikcoreCURE integrates with Apotechnik pharmacy POS systems, completing the set of major German pharmacy software integrations to maximize addressable pharmacy market.
Scale indicators5 records
Recent moves12 records
Expansion highlights7 records
CURE: One app, all things health competitors and assessment
Company assessmentDirect peers
- Apotal: German online pharmacy delivering OTC and prescription medications nationally. Direct competitor in the German online pharmacy space targeting the same consumer convenience proposition.
- Mayd: Berlin-based on-demand pharmacy delivery startup operating in Germany with a similar consumer-app model for OTC and prescription medication delivery from local pharmacies. Closest direct competitor to CURE in the German market.
- medpex: German online pharmacy offering OTC and prescription medication delivery to consumers. A direct German-market peer competing for the same digital pharmacy customer base.
Broad incumbents
- DocMorris: One of Europe's largest online pharmacies, headquartered in the Netherlands with significant German operations. Operates a vertically integrated mail-order pharmacy model rather than a marketplace; competes for the same digital pharmacy demand CURE serves.
- Shop Apotheke: Major European online pharmacy (publicly listed in Germany) operating across multiple EU countries. A broad incumbent competing with CURE's end customers for OTC and prescription delivery, though via owned warehouse fulfillment rather than local-pharmacy orchestration.
Emerging players
- Wellster Healthtech: Munich-based digital health platform operating telehealth and online pharmacy services across Europe. Adjacent competitor with overlapping consumer health acquisition and prescription fulfillment flows.
- Zava: European telehealth and online doctor/pharmacy platform operating across the UK, Germany, France, and Ireland. Overlaps with CURE on digital prescription workflows and consumer health delivery in Germany and France.
Regional players
- Capsule: US-based on-demand pharmacy delivery platform offering same-day prescription delivery via a consumer app. Operates in a different geography but pursues a directly analogous pharmacy delivery / marketplace model with similar unit economics dynamics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
CURE: One app, all things health social profiles
Digital presenceCURE: One app, all things health compliance and trust
Trust signalCompliance1 record
CURE: One app, all things health financial estimates
Financial estimateRevenue estimate
Valuation estimate
CURE: One app, all things health leadership team
Management profileNumber of profiles
Profiles8 records
CURE: One app, all things health subsidiaries and ownership
Company hierarchySubsidiaries1 record
CURE: One app, all things health funding detail
Funding detailFunding overview
Funding rounds2 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CURE: One app, all things health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CURE: One app, all things health
What does CURE: One app, all things health do?
CURE operates an AI-driven pharmacy platform that connects local pharmacies with end consumers through a unified order management dashboard integrated with delivery aggregators (Lieferando, Wolt) and its own consumer mobile app. Pharmacies receive orders across multiple channels in a single dashboard with automatic POS-based availability checks, while consumers can order over-the-counter and prescription medications (via e-prescription upload) for home delivery within approximately 30 minutes.
Is CURE: One app, all things health a public or private company?
CURE: One app, all things health is a private company. It is classified as venture growth investor backed and is currently operating.
When was CURE: One app, all things health founded?
CURE: One app, all things health was founded in 2021. It employs 11 to 50 people.
Where is CURE: One app, all things health based?
CURE: One app, all things health is headquartered in Berlin, Germany, in the Europe region.
How does CURE: One app, all things health make money?
Three revenue lines are on record. Commission per Order (Pharmacy-side) is the primary driver. The others are B2B Platform Licensing / Commission from Delivery Aggregators and prescription Delivery (E-Rezept).
Who are CURE: One app, all things health's main competitors?
Direct peers on record are Apotal, Mayd and medpex. Broad incumbents are DocMorris and Shop Apotheke. Emerging players are Wellster Healthtech and Zava. Capsule is listed as a regional player.
Does CURE: One app, all things health have an API?
No public API is recorded for CURE: One app, all things health.
What industry is CURE: One app, all things health in?
CURE: One app, all things health's product category is Pharmacy Delivery Platform. Its primary akta.pro industry code is HLALALAF, Telepharmacy & Prescription Fulfillment Marketplaces, with a secondary code of HLAFALAD, Mail-Order & Home Delivery Pharmacies. Its NAICS code is 456110 and its SIC code is 7372.